Vistagen Therapeutics, Inc. Common Stock

VTGN XNAS PHARMACEUTICAL PREPARATIONS

Market Cap

23M

Short interest (May 15)

4.5%

Net Short (Jun 03 ): 0.0%

Borrow Fee

1.26%

↑ 1.3%

Available Shares

2M

↓ 21.0%

Price Chart

Company Overview

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Company Info

Exchange: NASDAQ
Industry: PHARMACEUTICAL PREPARATIONS
CIK: 0001411685
Asset Type: CS

Market Data

Market Cap: $22,979,783
Employees: 59
Status: Active

Short Interest

Current Borrow Fee 1.26%
Range: 1.21% - 1.26%
Available Shares 2M
Range: 1.4M - 1.8M

Recent Changes

Fee Change: ↓ 2.4%
Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime